| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
* Trudeau Institute, Saranac Lake, NY 12983; and
Vaccine Research Institute of San Diego, San Diego, CA 92109
It is generally believed that the production of influenza-specific IgG in response to viral infection is dependent on CD4 T cells. However, we previously observed that CD40-deficient mice generate influenza-specific IgG during a primary infection, suggesting that influenza infection may elicit IgG responses independently of CD4 T cell help. In the present study, we tested this hypothesis and show that mice lacking CD40 or CD4 T cells produce detectable titers of influenza-specific IgG and recover from influenza infection in a manner similar to that of normal mice. In contrast, mice completely lacking B cells succumb to influenza infection, despite the presence of large numbers of functional influenza-specific CD8 effector cells in the lungs. Consistent with the characteristics of a T-independent Ab response, long-lived influenza-specific plasma cells are not found in the bone marrow of CD40–/– and class II–/– mice, and influenza-specific IgG titers wane within 60 days postinfection. However, despite the short-lived IgG response, CD40–/– and class II–/– mice are completely protected from challenge infection with the same virus administered within 30 days. This protection is mediated primarily by B cells and Ab, as influenza-immune CD40–/– and class II–/– mice were still resistant to challenge infection when T cells were depleted. These data demonstrate that T cell-independent influenza-specific Ab promotes the resolution of primary influenza infection and helps to prevent reinfection.
This article has been cited by other articles:
|
|
 |
|
  D. M. Carragher, D. A. Kaminski, A. Moquin, L. Hartson, and T. D. Randall A Novel Role for Non-Neutralizing Antibodies against Nucleoprotein in Facilitating Resistance to Influenza Virus J. Immunol., September 15, 2008; 181(6): 4168 - 4176. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Xu, P. A. Santini, A. J. Matthews, A. Chiu, A. Plebani, B. He, K. Chen, and A. Cerutti Viral Double-Stranded RNA Triggers Ig Class Switching by Activating Upper Respiratory Mucosa B Cells through an Innate TLR3 Pathway Involving BAFF J. Immunol., July 1, 2008; 181(1): 276 - 287. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Rangel-Moreno, D. M. Carragher, R. S. Misra, K. Kusser, L. Hartson, A. Moquin, F. E. Lund, and T. D. Randall B Cells Promote Resistance to Heterosubtypic Strains of Influenza via Multiple Mechanisms J. Immunol., January 1, 2008; 180(1): 454 - 463. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. S. Butler, A. A. Dandekar, and S. Perlman Antiviral Antibodies Are Necessary To Prevent Cytotoxic T-Lymphocyte Escape in Mice Infected with a Coronavirus J. Virol., December 15, 2007; 81(24): 13291 - 13298. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Bitsaktsis, B. Nandi, R. Racine, K. C. MacNamara, and G. Winslow T-Cell-Independent Humoral Immunity Is Sufficient for Protection against Fatal Intracellular Ehrlichia Infection Infect. Immun., October 1, 2007; 75(10): 4933 - 4941. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Sitati, E. E. McCandless, R. S. Klein, and M. S. Diamond CD40-CD40 Ligand Interactions Promote Trafficking of CD8+ T Cells into the Brain and Protection against West Nile Virus Encephalitis J. Virol., September 15, 2007; 81(18): 9801 - 9811. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Ostrowski, M. Vermeulen, O. Zabal, P. I. Zamorano, A. M. Sadir, J. R. Geffner, and O. J. Lopez The Early Protective Thymus-Independent Antibody Response to Foot-and-Mouth Disease Virus Is Mediated by Splenic CD9+ B Lymphocytes J. Virol., September 1, 2007; 81(17): 9357 - 9367. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Rangel-Moreno, J. E. Moyron-Quiroz, L. Hartson, K. Kusser, and T. D. Randall Pulmonary expression of CXC chemokine ligand 13, CC chemokine ligand 19, and CC chemokine ligand 21 is essential for local immunity to influenza PNAS, June 19, 2007; 104(25): 10577 - 10582. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. K. Heer, A. Shamshiev, A. Donda, S. Uematsu, S. Akira, M. Kopf, and B. J. Marsland TLR Signaling Fine-Tunes Anti-Influenza B Cell Responses without Regulating Effector T Cell Responses J. Immunol., February 15, 2007; 178(4): 2182 - 2191. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. M. Sitati and M. S. Diamond CD4+ T-Cell Responses Are Required for Clearance of West Nile Virus from the Central Nervous System J. Virol., December 15, 2006; 80(24): 12060 - 12069. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Kamperschroer, J. P. Dibble, D. L. Meents, P. L. Schwartzberg, and S. L. Swain SAP Is Required for Th Cell Function and for Immunity to Influenza J. Immunol., October 15, 2006; 177(8): 5317 - 5327. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. Brown, A. M. Dilzer, D. L. Meents, and S. L. Swain CD4 T cell-mediated protection from lethal influenza: perforin and antibody-mediated mechanisms give a one-two punch. J. Immunol., September 1, 2006; 177(5): 2888 - 2898. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. S. Hidmark, E. K. L. Nordstrom, P. Dosenovic, M. N. E. Forsell, P. Liljestrom, and G. B. Karlsson Hedestam Humoral Responses against Coimmunized Protein Antigen but Not against Alphavirus-Encoded Antigens Require Alpha/Beta Interferon Signaling J. Virol., July 15, 2006; 80(14): 7100 - 7110. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
